0001784593-19-000002.txt : 20190812 0001784593-19-000002.hdr.sgml : 20190812 20190812163951 ACCESSION NUMBER: 0001784593-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190812 DATE AS OF CHANGE: 20190812 EFFECTIVENESS DATE: 20190812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xione Therapeutics, Inc. CENTRAL INDEX KEY: 0001784593 IRS NUMBER: 834540480 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-346356 FILM NUMBER: 191017001 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BOULEVARD., SUITE J CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 713-331-9443 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BOULEVARD., SUITE J CITY: HOUSTON STATE: TX ZIP: 77021 D 1 primary_doc.xml X0708 D LIVE 0001784593 Xione Therapeutics, Inc. 2450 HOLCOMBE BOULEVARD., SUITE J HOUSTON TX TEXAS 77021 713-331-9443 DELAWARE None None Corporation true 2019 Eric J. Devroe 2450 Holcombe Boulevard Suite J Houston TX TEXAS 77021 Executive Officer Director Biotechnology Decline to Disclose 06b false 2019-06-05 false true true true false 0 200000 90000 110000 false 4 0 0 0 false Xione Therapeutics, Inc. Eric J. Devroe Eric J. Devroe President and Chief Executive Officer 2019-08-12